Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

November 30, 2005

Conditions

Acute Spinal Cord Injury.

Interventions

DRUG

Risedronate

Trial Locations (2)

Hamilton Health Sciences, Chedoke Site, Hamilton

Toronto Rehab, Lyndhurst Centre, Toronto

All Listed Sponsors

collaborator

Ontario Neurotrauma Foundation

OTHER

collaborator

St. Joseph's Healthcare Foundation

OTHER

collaborator

Queen Elizabeth Hospital NHS Foundation Trust

OTHER

lead

Toronto Rehabilitation Institute

OTHER

NCT00150696 - Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. | Biotech Hunter | Biotech Hunter